REAL-WORD EFFECTIVENESS OF 8, 12 AND 24 WEEKS LEDIPASVIR (LDV)/SOFOSBUVIR (SOF)-BASED THERAPY FOR HEPATITIS C VIRUS (HCV) GENOTYPE 1: ANALYSIS IN A LARGE INTEGRATED HEALTH CARE SYSTEM

被引：3
|
作者：
Lai, J. [1 ,2 ]
Witt, M. [3 ]
Witt, D. [3 ]
机构：
[1] Kaiser Permanente, Gastroenterol, San Rafael, CA USA
[2] Kaiser Permanente, Infect Dis, San Rafael, CA USA
[3] Kaiser Permanente Med Ctr, Infect Dis, San Rafael, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)01517-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-177
引用
收藏
页码：S778 / S778
页数：1
相关论文
共 47 条
  • [1] Real-Word Effectiveness of Ledipasvir (LDV)/Sofosbuvir (SOF)-Based Therapy for Hepatitis C Virus (HCV): Preliminary Analysis in a Large Integrated Health Care System
    Lai, Jennifer B.
    Witt, David J.
    [J]. HEPATOLOGY, 2015, 62 : 725A - 726A
  • [2] Real-Word Effectiveness of Sofosbuvir/Velpatasvir (SOF/VEL)-Based Therapy for Hepatitis C Virus (HCV) Genotype (GT) 2 and 3: Analysis in a Large North American Integrated Health Care System
    Lai, Jennifer B.
    Ready, Joanna B.
    Witt, Maxwell A.
    Witt, David J.
    [J]. HEPATOLOGY, 2017, 66 : 817A - 817A
  • [3] Real world effectiveness of ledipasvir/sofosbuvir (LDV/SOF) for 8 weeks in patients coinfected with HCV and HIV-1
    Buggisch, P.
    Moreno, A.
    Isakov, V.
    Backus, L.
    Ain, D.
    Ruane, P.
    Gonzalez, J.
    Naik, S.
    Mehta, S.
    Lee, J.
    Mertens, M.
    Natha, M.
    Kersey, K.
    Osinusi, A.
    Zhdanov, K.
    Berenguer, J.
    Zeuzem, S.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S729 - S730
  • [4] Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV)
    Brown, Ashley N.
    Liu, Lin
    Rodriquez, Jaime L.
    Zhao, Lisa
    Schuster, Layla
    Li, Eric
    Wang, Gary P.
    Neely, Michael N.
    Yamada, Walter
    Drusano, George L.
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [5] Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV)
    Ashley N. Brown
    Lin Liu
    Jaime L. Rodriquez
    Lisa Zhao
    Layla Schuster
    Eric Li
    Gary P. Wang
    Michael N. Neely
    Walter Yamada
    George L. Drusano
    [J]. Scientific Reports, 7
  • [6] REAL-WORLD EFFECTIVENESS OF SOFOSBUVIR (SOF), TELAPREVIR, AND BOCEPREVIR (T, B) BASED THERAPY FOR HEPATITIS C VIRUS (HCV): AN ANALYSIS IN A LARGE INTEGRATED HEALTH CARE SYSTEM
    Lai, J. B.
    Witt, D. J.
    Witt, M. A.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S658 - S658
  • [7] Real World Effectiveness of 8 vs 12 Weeks of Ledipasvir/Sofosbuvir (LDV/SOF) in Blacks with HCV: A Comparative Analysis of Clinical Trials with Real World Cohorts
    Wilson, Eleanor
    Davitkov, Perica
    Kwo, Paul Y.
    Kattakuzhy, Sarah
    Qureshi, Kamran
    Sundaram, Vinay
    Naik, Sarjita
    Williams, Laurie A.
    Wolf, John
    Llewellyn, Joseph
    Osinusi, Anu O.
    Brainard, Diana M.
    Gordon, Stuart C.
    Backus, Lisa I.
    Kowdley, Kris V.
    [J]. HEPATOLOGY, 2017, 66 : 608A - 608A
  • [8] Real-World Retreatment of Sofosbuvir/Ledipasvir (SOF/LDV) Failures In Hepatitis C Virus Genotype 1 infection
    Pearlman, Brian
    Hinds, Andrew
    Perrys, Michael
    [J]. HEPATOLOGY, 2016, 64 : 478A - 478A
  • [9] Ledipasvir/Sofosbuvir (LDV/SOF) for 12 or 24 Weeks Is Safe and Effective in Kidney Transplant Recipients with Chronic Genotype 1 or 4 HCV Infection
    Pol, S.
    Aghemo, A.
    Lin, L.
    Hyland, R.
    Yun, C.
    Spellman, J.
    Natha, M.
    Brainard, D.
    McHutchison, J.
    Bourliere, M.
    Peck-Radosavljevic, M.
    Michael, M.
    Colombo, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 262 - 262
  • [10] SIX WEEKS OF SOFOSBUVIR/ LEDIPASVIR (SOF/LDV) ARE SUFFICIENT TO TREAT ACUTE HEPATITIS C VIRUS GENOTYPE 1 MONOINFECTION: THE HEPNET ACUTE HCV IV STUDY
    Deterding, K.
    Spinner, C.
    Schott, E.
    Welzel, T.
    Gerken, G.
    Klinker, H.
    Spengler, U.
    Wiegand, J.
    zur Wiesch, J. Schulze
    Pathil, A.
    Cornberg, M.
    Umgelter, A.
    Zoellner, C.
    Zeuzem, S.
    von der Leyen, H.
    von Witzendorff, D.
    Manns, M. P.
    Wedemeyer, H.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S211 - S211
12345